Perfusion Systems Market Rising Need for The Organ Transplantation is expected to boost the market growth over the years

According to The Insight Partners market research study titled 'Perfusion Systems Market - Global Analysis and Forecasts by Type, Component, the global perfusion systems market is expected to reach US$ 1,442.28 Mn in 2027 from US$ 1,044.75 Mn in 2018. The market is estimated to grow with a CAGR of 3.8% from 2019-2027. The report highlights the trends prevalent in the global perfusion systems market and the factors driving the market along with those that act as deterrents to its growth.

The Asia Pacific perfusion systems market is expected to grow at highest rate during the forecast period owing higher number of research & development and increasing investments on perfusion systems. In addition, emergence of new local players with competitive product portfolio are expected to fuel the market growth in Asia Pacific region.   

Get sample PDF Copy at:

Perfusion Systems Market: Competition Landscape & Key Developments

Some of the prominent players operating in perfusion systems market are REPLIGEN CORPORATION, Merck KGaA, Ala Scientific Instruments, Inc., XVIVO Perfusion, Medtronic, XENIOS AG (Fresenius Medical Care AG & Co. KGaA), Getinge AB, TERUMO CORPORATION, LivaNova PLC, Sartorius AG, Harvard Bioscience, RAND, Sanisure (Sani-Tech West, Inc.), AutoMate Scientific, Inc., Jobst Technologies GmbH, APD (Advanced Perfusion Diagnostics), Spectrum Medical, Transonic Systems Inc, OrganOx, ISCHEMAVIEW, INC, and CESCO BIOENGINEERING CO., LTD.

The market players are focused towards bringing new and innovative products to sustain their position in the market. For instance, in March 2018, Sartorius Stedim Biotech (Sartorius AG) launched ambr 250 high throughput (ht) perfusion, specially designed for rapid cell culture perfusion process development to optimize production of therapeutic antibodies. The developments performed by the companies are helping the market to grow in the coming years.

Rising Need for The Organ Transplantation is expected to boost the market growth over the years

Organ transplantation is a surgical process done when a patient’s organ has stopped functioning completely. The organ transplant is commonly done for the organs such as heart, liver and kidney. However, the rising cases of the chronic diseases are leading to the need of the transplantation for the other organs such as lung, pancreases, cornea, and vascular tissues among others. The organ transplantation surgeries are rising across the world. For instance, in Spain, approximately 5,260 transplant surgeries were performed, among which nearly 3,200 were kidney transplant and around 1,200 were liver transplant surgeries. The number of heart transplant surgeries were approximately 300 and lung were nearly 360. The public-private partnership in assistance with the transplant coordinators has enormously contributed to the improvement of the organ transplantation.

As per the National Chronic Kidney Disease fact sheet 2017, states that approximately, 30 million people in US are estimated to have chronic kidney diseases. Similarly, according to the National Institute id Diabetes and Digestive and Kidney Diseases states that nearly 661,000 Americans have kidney failure among these nearly, 468,000 patients are taking dialysis, and approximately 193,000 have undergone kidney transplantation. Therefore, the increasing incidences are likely to grow more needs for the kidney transplantation in the coming years. Likewise, it is estimated that the growing numbers of the heart diseases are also responsible to drive the market in coming futures.

Rising Cell Based Research Activities

The rise in the chronic diseases, advantages of the applications of biotechnology are growing the extensive cell based research activities. The cell based assays assists in understanding the challenges of biology of the living organisms. The cell based assays helps in the understanding the aspects such as cell signaling, proliferation, apoptosis, cellular genetics, neurology, cancer and more.  The cell based assays are extensively carried out in pharmaceutical, biotechnology industries, research institutes and academics research institutes. The pharmaceutical and biopharmaceutical industries need to efficiently commercialize the drug. Therefore, cell based assays in the pharmaceutical and biotechnology industry are the driving factor for the growth of the perfusion systems.

The cell based assays are also extensively carried out by the contract research organization for the clinical trial studies and other processes. The chronic diseases such as cancer and other genetic related studies are enforcing for the cell based studies. For instance, Charles River offers services for the human primary cell based assays and according to an article published by the company states that the development in the cell based assays are likely to continue growing in the future.

Perfusion Systems Market: Segmental Overview

The global perfusion systems market on the basis of component was segmented into oxygenators, heart-lung machine, perfusion pumps, monitoring systems, cannulas, and others. In 2018, the oxygenators segment held a largest market share of 33.1% of the perfusion systems market, by component. This segment is also expected to dominate the market in 2027 owing to the increasing number of the cardiovascular surgeries, liver transplantation and kidney transplantation worldwide. Moreover, the heart-lung machine segment is anticipated to witness the significant growth rate of 3.3% during the forecast period, 2019 to 2027 owing to the incidences of the coronary heart diseases.

The perfusion systems market by type is segmented into bioreactor perfusion systems, microfluidic perfusion systems, gravity or pressure driven perfusion systems, and small mammal organ perfusion systems.  In 2018, the bioreactor perfusion systems segment held a largest market share of 44.3% of the perfusion systems market, by type. This segment is also expected to dominate the market in 2027 owing to increasing production by the biopharmaceutical and pharmaceutical and its advantages including, high quality of product, product stability, and scalability. Moreover, the microfluidic perfusion systems segment is anticipated to witness the significant growth rate of 3.9% during the forecast period, 2019 to 2027 owing to increasing application of basic cell biology, molecular biological assays, tissue engineering, and systems biology.

Buy Complete Report of Perfusion Systems Market Study at:

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

We are committed to provide highest quality research and consulting services to our customers. We help our clients understand the key market trends, identify opportunities, and make informed decisions with our market research offerings at an affordable cost.

Contact Us

Contact Person: Sameer Joshi

Phone: +1-646-491-9876



Back to news